75 results
DEFR14A
BTAX
Biostax Corp.
21 Oct 19
Revised proxy
2:40pm
Additional Materials
Soliciting Material under §240.14a-12
IMMUNE THERAPEUTICS, INC.
(Name of Registrant As Specified In Its Charter)
Payment of Filing … ):
Proposed maximum aggregate value of transaction:
Total fee paid:
Fee paid previously with preliminary materials.
Check box if any part of the fee is offset
8-K
EX-10.1
BTAX
Biostax Corp.
20 May 16
Other Events
12:00am
the Active Pharmaceutical Ingredients (the “API”) and raw materials that have been previously approved by IMUN and only in the amounts that have been … previously indicated in writing;
To obtain and pay for an insurance policy that protects the raw materials that are provided by IMUN and the finished LDN
10-12G/A
EX-10.12
BTAX
Biostax Corp.
23 Aug 13
Registration of securities (amended)
12:00am
;
To obtain all permits and licenses necessary to import the raw materials tax free, under the temporary importation regime and to export the finished LDN … ;
To use only the raw materials that have either been provided by TNI or previously approved by TNI and only in the amounts that been previously indicated
DEFR14A
b025djmrqp9bn
5 Sep 19
Revised proxy
9:46am
8-K
EX-10.1
5zgd42aypzzs4twu87
15 Dec 14
Entry into a Material Definitive Agreement
12:00am
8-K
3orfh1jo05yic46 2k
15 Dec 14
Entry into a Material Definitive Agreement
12:00am
8-K
oreas v79y3o1
14 May 20
Other Events
10:08am
D
7edr3da5y rjace
2 Oct 12
$3M in equity / options, sold $200K, 2 investors
12:00am
D
5pqnyu2jr91oh s455
31 Aug 22
$5M in debt
2:58pm
8-K
EX-17.1
odk3c4rut yw4udmblx2
9 Nov 22
Entry into a Material Definitive Agreement
5:00pm
D/A
86kdc6i46 t2
25 Sep 13
Indefinite amount in equity / options, sold $2.89M, 35 investors
12:00am
8-K
EX-10.1
gfhff15r igmsf0itpo
12 Oct 22
Entry into a Material Definitive Agreement
8:49am
8-K
EX-10.1
bu55myn
11 Jun 18
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
5c8bp fqdzsxke
9 Jul 13
Other Events
12:00am